Related Experiment Videos
Nonmetastatic gestational trophoblastic disease
1Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.
Obstetrics and Gynecology Clinics of North America
|September 1, 1988
Summary
Gestational trophoblastic disease, a group of placental neoplasms, is highly curable with chemotherapy. Most patients achieve remission and can preserve fertility, with many having successful future pregnancies.
Area of Science:
- Gynecology
- Oncology
- Perinatology
Background:
- Gestational trophoblastic disease (GTD) comprises various human placental neoplasms.
- Effective chemotherapy has dramatically improved cure rates for GTD.
- Management strategies aim for remission with minimal toxicity and preserved fertility.
Purpose of the Study:
- To review the management of nonmetastatic gestational trophoblastic disease.
- To highlight the efficacy of chemotherapy and the role of hysterectomy.
- To emphasize fertility preservation and outcomes of subsequent pregnancies.
Main Methods:
- Review of current treatment protocols for nonmetastatic GTD.
- Analysis of chemotherapy regimens and their toxicity profiles.
- Evaluation of the role of hysterectomy in specific clinical scenarios.
Main Results:
- Nearly all patients with nonmetastatic GTD can achieve cure with chemotherapy.
- Hysterectomy can reduce chemotherapy requirements and salvage treatment failures.
- The majority of treated patients retain reproductive capacity.
Conclusions:
- Nonmetastatic GTD is a curable condition with modern chemotherapeutic approaches.
- Fertility preservation is achievable in most patients undergoing GTD treatment.
- Successful pregnancies are common following successful GTD therapy.